Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$311,298,695
+$24,419,351 QoQ
Shares Held
2,037,962
-2.1% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
3.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 66.68593428140466.ToString("F0")%
None 33.314065718595344.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cullen Capital Management, LLC holds $1,034,794,112 across 8 Drug Manufacturers - General names. NVS ranks #1 (30.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
2,037,962 | $311,298,695 | |
| 2 | JNJ |
Johnson & Johnson
|
1,114,929 | $272,533,244 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,073,354 | $249,403,752 | |
| 4 | PFE |
Pfizer Inc
|
2,693,507 | $75,633,676 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,119,669 | $67,907,924 | |
| 6 | NVO |
Novo Nordisk A S
|
792,355 | $29,119,046 | |
| 7 | SNY |
Sanofi
|
593,301 | $28,585,242 | |
| 8 | ABBV |
AbbVie Inc.
|
1,437 | $312,533 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $311,298,695 | 2,037,962 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $286,879,344 | 2,080,796 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $265,505,146 | 2,070,377 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $253,740,060 | 2,096,852 | Shares | Sole | 2025-09-30 | |
| 2025-03-31 | $235,076,092 | 2,108,684 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $209,860,594 | 2,156,619 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $259,021,359 | 2,251,968 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $305,580,761 | 2,870,381 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $282,879,533 | 2,924,424 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $164,504,160 | 1,629,238 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $276,530,444 | 2,714,809 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $282,133,259 | 2,795,890 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $318,320,276 | 3,460,003 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $252,901,322 | 2,787,713 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $263,547,420 | 3,467,273 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $284,302,453 | 3,363,332 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $289,160,030 | 3,295,271 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $245,145,871 | 2,802,628 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $245,228,615 | 2,998,638 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $261,638,637 | 2,867,587 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $221,621,260 | 2,592,668 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $49,578,205 | 525,026 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $56,083,547 | 644,935 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $56,648,724 | 648,600 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $63,125,369 | 765,620 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||